Abstract:The discovery and advances of medicines may be considered as the ultimate relevant translational science effort that adds to human invulnerability and happiness. But advancing a fresh medication is a quite convoluted, costly, and protracted operation, normally costing USD ~2.6 billion and consuming a mean time span of 12 years. Methods to cut back expenditure and hasten new drug discovery have prompted an arduous and compelling brainstorming exercise in the pharmaceutical industry. The engagement of Artificial Intelligence (AI), including the deep-learning (DL) component in particular, has been facilitated by the employment of classified big data, in concert with strikingly reinforced computing prowess and cloud storage, across all fields. AI has energized computer-facilitated drug discovery. An unrestricted espousing of machine learning (ML), especially DL, in many scientific specialties, and the technological refinements in computing hardware and software, in concert with various aspects of the problem, sustain this progress. ML algorithms have been extensively engaged for computer-facilitated drug discovery. DL methods, such as artificial neural networks (ANNs) comprising multiple buried processing layers, have of late seen a resurgence due to their capability to power automatic attribute elicitations from the input data, coupled with their ability to obtain nonlinear input-output pertinencies. Such features of DL methods augment classical ML techniques which bank on human-contrived molecular descriptors. A major part of the early reluctance concerning utility of AI in pharmaceutical discovery has begun to melt, thereby advancing medicinal chemistry. AI, along with modern experimental technical knowledge, is anticipated to invigorate the quest for new and improved pharmaceuticals in an expeditious, economical, and increasingly compelling manner. DL-facilitated methods have just initiated kickstarting for some integral issues in drug discovery. Many technological advances, such as "message-passing paradigms", "spatial-symmetry-preserving networks", "hybrid de novo design", and other ingenious ML exemplars, will definitely come to be pervasively widespread and help dissect many of the biggest, and most intriguing inquiries. Open data allocation and model augmentation will exert a decisive hold during the progress of drug discovery employing AI. This review will address the impending utilizations of AI to refine and bolster the drug discovery operation.

Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions

Exploring the applications of formulation-based drug development strategies in neurological disorders using artificial intelligence and machine learning approaches

Artificial intelligence in drug discovery: recent advances and future perspectives

Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development

A review on artificial intelligence and machine learning used in pharmaceutical research

Exploring the Artificial Intelligence and Machine Learning Models in the Context of Drug Design Difficulties and Future Potential for the Pharmaceutical Sectors

Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries

Artificial Intelligence in The Management of Neurodegenerative Disorders

Unlocking therapeutic frontiers: harnessing artificial intelligence in drug discovery for neurodegenerative diseases

Evaluating the Impact of AI and ML on Modern Drug Discovery

Application of Artificial Intelligence and Machine Learning in Drug Discovery and Development

A Comprehensive Review on Machine Learning and Deep Learning Methods in Drug Discovery

Artificial intelligence for drug discovery and development in Alzheimer's disease

The potential applications of artificial intelligence in drug discovery and development

Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery

Unleashing the future: The revolutionary role of machine learning and artificial intelligence in drug discovery

Artificial Intelligence in Pharmaceutical Sciences

Artificial Intelligence for Drug Discovery: Resources, Methods, and Applications

Artificial intelligence to deep learning: machine intelligence approach for drug discovery

Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery

From understanding diseases to drug design: can artificial intelligence bridge the gap?